UK Housebuilding Sector in 3Q 2018… …trains, cows and beyond

Hardman & Co

Hardman & Co Report Report DownloadsThe wit of Mauricio Pochettino

“It’s like the cow that every single day during 10 years sees the train crossing in front of it at the same time. And if you ask the cow what time is the train going to come, it’s not going to have the right answer. In football it’s the same”.
Such was the Delphic comment from Tottenham Hotspur’s Argentinian Manager in September coming off back-to-back losses in the Premier League.
By way of elucidation, too, Pochettino added: “experience on its own is not going to help you in the future”.

Isn’t it the same in the beautiful game of Housebuilding in the 2018-19 season?

Share on:

Latest Company News

Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video)

Elemental Royalty CEO David Cole explains how smart capital allocation and discovery optionality turn modest royalty deals into multi-decade, cash-generating assets with scale.

FirstGroup selected as preferred operator for London Overground contract

FirstGroup has been named the preferred operator for the London Overground rail network under a new contract awarded by Transport for London.

Volution Group to acquire Australian ventilation specialist ACI for AU$150 million

Volution Group has agreed to acquire AC Industries, a Sydney-based manufacturer of ventilation ducting solutions for underground mines.

Berkeley Group posts £254 million profit and maintains strong cash position in interim results

Berkeley Group has reported pre-tax profit of £254 million for the six months to 31 October 2025 and net cash of £342 million.

GSK receives US FDA Orphan Drug Designation for SCLC treatment risvutatug rezetecan

GSK has announced that its B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, has been granted Orphan Drug Designation by the US FDA for small-cell lung cancer.

Fidelity China HY Report Highlights Strong Scalable Growth in Core Domestic Industries (LON: FCSS)

Fidelity China Special Situations reported strong half-year results for the six months to 30 September 2025, delivering a share price return of 28.7% and a NAV return of 29.7%.

    Search

    Search